Showing results (861-870 of 2,400) with videos related to

Sort By:
Pageof 240
Future Medicinal Chemistry|August 1, 2015
Carbonic anhydrase IX inhibitors in cancer therapy: an updateClaudiu T Supuran, Jean-Yves Winum
Future Medicinal Chemistry|December 16, 2014
The search for a common structural moiety among selected pharmacological correctors of the mutant CFTR chloride channelErika Nieddu, Benedetta Pollarolo, Marco T Mazzei, et al.
Future Medicinal Chemistry|December 16, 2014
Isoxazolotacrines as non-toxic and selective butyrylcholinesterase inhibitors for Alzheimer's diseaseOussama Cherif, Fatma Allouche, Fakher Chabchoub, et al.
Future Medicinal Chemistry|December 16, 2014
"Too little, too late?" Will inhibitors of the hepatitis C virus p7 ion channel ever be used in the clinic?Stephen Griffin
Future Medicinal Chemistry|December 16, 2014
Histone methylases as novel drug targets: developing inhibitors of EZH2Catherine Baugé, Céline Bazille, Nicolas Girard, et al.
Future Medicinal Chemistry|December 16, 2014
miRNA-based therapies: strategies and delivery platforms for oligonucleotide and non-oligonucleotide agentsVolker Baumann, Johannes Winkler
Future Medicinal Chemistry|January 10, 2015
Cancer cell metabolism as new targets for novel designed therapiesIgor Marín de Mas, Esther Aguilar, Anusha Jayaraman, et al.
Future Medicinal Chemistry|December 23, 2014
Practical permeability-based hepatic clearance classification system (HepCCS) in drug discoveryPeter W Fan, Yang Song, Leonid M Berezhkovskiy, et al.
Future Medicinal Chemistry|December 23, 2014
Chemoinformatics for medicinal chemistry: in silico model to enable the discovery of potent and safer anti-cocci agentsAlejandro Speck-Planche, Maria Natália Dias Soeiro Cordeiro
Future Medicinal Chemistry|December 23, 2014
Extending in silico mechanism-of-action analysis by annotating targets with pathways: application to cellular cytotoxicity readoutsSonia Liggi, Georgios Drakakis, Alexios Koutsoukas, et al.
Pageof 240